FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original ANDA for olmesartan medoxomil, a generic angiotensin II receptor blocker for hypertension. The approval confirms a generic version of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)